Exploring the Link Between Bevacizumab and Gastrointestinal Perforations Using the FDA Adverse Event Reporting System Database

被引：0
|
作者：
Wichelmann, Thomas A. [1 ]
Abdulmujeeb, Sufyan [1 ]
Ehrenpreis, Eli D. [1 ]
机构：
[1] Advocate Lutheran Gen Hosp, Park Ridge, IL USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2020年 / 115卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S0236
引用
收藏
页码：S114 / S115
页数：3
相关论文
共 50 条
  • [41] Exploring the association between weight loss-inducing medications and multiple sclerosis: insights from the FDA adverse event reporting system database
    Shirani, Afsaneh
    Cross, Anne H.
    Stuve, Olaf
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2024, 17
  • [42] Botulinum Toxin Type A Overdoses: Analysis of the FDA Adverse Event Reporting System Database
    Rashid Kazerooni
    Edward P. Armstrong
    Clinical Drug Investigation, 2018, 38 : 867 - 872
  • [43] Botulinum Toxin Type A Overdoses: Analysis of the FDA Adverse Event Reporting System Database
    Kazerooni, Rashid
    Armstrong, Edward P.
    CLINICAL DRUG INVESTIGATION, 2018, 38 (09) : 867 - 872
  • [44] Analysis of ADR reports of cetuximab based on the FDA adverse event reporting system database
    Zhao, Shuai
    Wang, Yan
    Deng, Xiaoli
    Chen, Xi
    Lu, Zhaoyi
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [45] Botulinum toxin type A overdoses: analysis of the FDA adverse event reporting system database
    Kazerooni, Rashid
    NEUROLOGY, 2019, 92 (15)
  • [46] Triptans and serious adverse vascular events: Data mining of the FDA Adverse Event Reporting System database
    Roberto, Giuseppe
    Piccinni, Carlo
    D'Alessandro, Roberto
    Poluzzi, Elisabetta
    CEPHALALGIA, 2014, 34 (01) : 5 - 13
  • [47] Interaction between paracetamol and lamotrigine: new insights from the FDA Adverse Event Reporting System (FAERS) database
    Carnovale, Carla
    Mosini, Giulia
    Gringeri, Michele
    Battini, Vera
    Mazhar, Faizan
    Pozzi, Marco
    Clementi, Emilio
    Radice, Sonia
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 75 (09) : 1323 - 1325
  • [48] Pharmacovigilance analysis of orlistat adverse events based on the FDA adverse event reporting system (FAERS) database
    Zhu, Jinfeng
    Hu, Mianda
    Liang, Yingshi
    Zhong, Mingjun
    Chen, Zilin
    Wang, Zhenjie
    Yang, Yujia
    Luo, Ziyi
    Zeng, Wenqi
    Li, Jiahui
    Du, Yikuan
    Liu, Yi
    Yang, Chun
    HELIYON, 2024, 10 (14)
  • [49] Interaction between paracetamol and lamotrigine: new insights from the FDA Adverse Event Reporting System (FAERS) database
    Carla Carnovale
    Giulia Mosini
    Michele Gringeri
    Vera Battini
    Faizan Mazhar
    Marco Pozzi
    Emilio Clementi
    Sonia Radice
    European Journal of Clinical Pharmacology, 2019, 75 : 1323 - 1325
  • [50] Gastrointestinal adverse events associated with semaglutide: A pharmacovigilance study based on FDA adverse event reporting system
    Shu, Yamin
    He, Xucheng
    Wu, Pan
    Liu, Yanxin
    Ding, Yufeng
    Zhang, Qilin
    FRONTIERS IN PUBLIC HEALTH, 2022, 10
12345